Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
Neurosurgery
|
August 16, 2011
Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment
Aaron J Clark, Kathleen R Lamborn, Nicholas A Butowski, et al.
Neuro-Oncology Practice
|
August 7, 2019
Attitudes toward fertility and fertility preservation in women with glioma
Rachel K Stiner, Jennifer L Clarke, Nikita Sinha, et al.
Cancers
|
April 27, 2024
Automatic Brain Tissue and Lesion Segmentation and Multi-Parametric Mapping of Contrast-Enhancing Gliomas without the Injection of Contrast Agents: A Preliminary Study
Jing Liu, Angela Jakary, Javier E Villanueva-Meyer, et al.
Journal of Neuro-Oncology
|
August 29, 2018
Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma
Jennie W Taylor, Mili Parikh, Joanna J Phillips, et al.
Neuro-Oncology Advances
|
October 30, 2023
Quantitative analysis of <i>MGMT</i> promoter methylation in glioblastoma suggests nonlinear prognostic effect
David Gibson, Akshay Ravi, Eduardo Rodriguez, et al.
Journal of Neurosurgery
|
December 15, 2010
Impact of bevacizumab chemotherapy on craniotomy wound healing
Aaron J Clark, Nicholas A Butowski, Susan M Chang, et al.
Neuro-Oncology
|
March 5, 2010
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)
Fabio M Iwamoto, Kathleen R Lamborn, H Ian Robins, et al.
Journal of Neuro-Oncology
|
June 14, 2021
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma
Nancy Ann Oberheim Bush, Jacob S Young, Yalan Zhang, et al.
Neuro-Oncology
|
December 18, 2019
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)
Timothy F Cloughesy, Andrew Brenner, John F de Groot, et al.
Neuro-Oncology
|
December 17, 2013
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
Orin Bloch, Courtney A Crane, Yelena Fuks, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
Neurosurgery
|
August 16, 2011
Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment
Aaron J Clark, Kathleen R Lamborn, Nicholas A Butowski, et al.
Neuro-Oncology Practice
|
August 7, 2019
Attitudes toward fertility and fertility preservation in women with glioma
Rachel K Stiner, Jennifer L Clarke, Nikita Sinha, et al.
Cancers
|
April 27, 2024
Automatic Brain Tissue and Lesion Segmentation and Multi-Parametric Mapping of Contrast-Enhancing Gliomas without the Injection of Contrast Agents: A Preliminary Study
Jing Liu, Angela Jakary, Javier E Villanueva-Meyer, et al.
Journal of Neuro-Oncology
|
August 29, 2018
Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma
Jennie W Taylor, Mili Parikh, Joanna J Phillips, et al.
Neuro-Oncology Advances
|
October 30, 2023
Quantitative analysis of <i>MGMT</i> promoter methylation in glioblastoma suggests nonlinear prognostic effect
David Gibson, Akshay Ravi, Eduardo Rodriguez, et al.
Journal of Neurosurgery
|
December 15, 2010
Impact of bevacizumab chemotherapy on craniotomy wound healing
Aaron J Clark, Nicholas A Butowski, Susan M Chang, et al.
Neuro-Oncology
|
March 5, 2010
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)
Fabio M Iwamoto, Kathleen R Lamborn, H Ian Robins, et al.
Journal of Neuro-Oncology
|
June 14, 2021
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma
Nancy Ann Oberheim Bush, Jacob S Young, Yalan Zhang, et al.
Neuro-Oncology
|
December 18, 2019
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)
Timothy F Cloughesy, Andrew Brenner, John F de Groot, et al.
Neuro-Oncology
|
December 17, 2013
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
Orin Bloch, Courtney A Crane, Yelena Fuks, et al.
Page
of 6